Drawing for IBIS BIOSCIENCES

USPTO serial 78844201

IBIS BIOSCIENCES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PILARO, MARK F
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IBIS BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary L. Winburn

Mary L. Winburn Abbott Laboratories100 Abbott Park RoadD377/AP6AAbbott Park, IL 60064-6008

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological research services in the areas of analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific and research use; development for others and leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific and research use; development for others and leasing to others of computer software and hardware for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of computer software and hardware for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; development for others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; development for others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; development for others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical useACTIVE—
044Leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 7, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 7, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 4, 2009EX3GSOU EXTENSION 3 GRANTED—
Nov 2, 2009EXT3SOU EXTENSION 3 FILED—
Nov 2, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 10, 2009EX2GSOU EXTENSION 2 GRANTED—
Mar 9, 2009EXT2SOU EXTENSION 2 FILED—
Mar 9, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2008ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 7, 2008EX1GSOU EXTENSION 1 GRANTED—
Nov 6, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 5, 2008EXT1SOU EXTENSION 1 FILED—
Nov 5, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 12, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 23, 2008NPUBNOTICE OF PUBLICATION—
Jan 9, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 9, 2008ALIEASSIGNED TO LIE—
Nov 21, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2007ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 5, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 11, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 8, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 4, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 4, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 4, 2007ALIEASSIGNED TO LIE—
Nov 29, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2006GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 6, 2006CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 7, 2006DOCKASSIGNED TO EXAMINER—
Mar 29, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance